| 000 | 00910 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514002714.0 | ||
| 264 | 0 | _c20010628 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(00)04427-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBöttger, E C | |
| 245 | 0 | 0 |
_aDrug-resistant tuberculosis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cApr 2001 |
||
| 300 |
_a1288-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 773 | 0 |
_tLancet (London, England) _gvol. 357 _gno. 9264 _gp. 1288-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(00)04427-5 _zAvailable from publisher's website |
| 999 |
_c11350876 _d11350876 |
||